CRVS · Corvus Pharmaceuticals, Inc.

Summary

Corvus Pharmaceuticals, Inc. filed an 8-K on March 12, 2026, under Item 2.02 disclosing results of operations via Exhibit 99.1 press release, which is not deemed 'filed' for Section 18 purposes. The filing includes Item 9.01 listing the press release as Exhibit 99.1 and Cover Page Interactive Data as Exhibit 104.

Key takeaways

• Form 8-K filed on 2026-03-12
• Item 2.02: Results of Operations disclosed
• Exhibit 99.1: Press release dated March 12, 2026
• Exhibit 104: Cover Page Interactive